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Labeling adipose derived stem 
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paramagnetic Fe3O4 nanoparticles 
and magnetic resonance tracking  
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Shukui Zhou1,*, Ting Yin2,*, Qingsong Zou1, Kaile Zhang1, Guo Gao2, Joseph G. Shapter3, 
Peng Huang2 & Qiang Fu1
Cell sheet therapy has emerged as a potential therapeutic option for reparation and reconstruction 
of damaged tissues and organs. However, an effective means to assess the fate and distribution of 
transplanted cell sheets in a serial and noninvasive manner is still lacking. To investigate the feasibility 
of tracking Adipose derived stem cells (ADSCs) sheet in vivo using ultrasmall super-paramagnetic Fe3O4 
nanoparticles (USPIO), canine ADSCs were cultured and incubated with USPIO and 0.75 μg/ml Poly-L-
Lysine (PLL) for 12 h. Labeling efficiency, cell viability, apoptotic cell rate were assessed to screen the 
optimum concentrations of USPIO for best labeling ADSCs. The results showed ADSCs were labeled by 
USPIO at an iron dose of 50 μg/ml for a 12 h incubation time, which can most efficiently mark cells and 
did not impair the cell survival, self-renewal, and proliferation capacity. USPIO-labeled ADSCs sheets 
can be easily and clearly detected in vivo and have persisted for at least 12 weeks. Our experiment 
confirmed USPIO was feasible for in vivo labeling of the ADSCs sheets with the optimal concentration of 
50 μg Fe/ml and the tracing time is no less than 12 weeks.
Cell sheet technology has been widely applied in the field of regenerative medicine and tissue engineering for the 
past few years. In the absence of a biomaterial scaffold, it requires the non-enzymatic harvesting of cultured cells 
and creates a contiguous sheeting structure with extracellular matrix (ECM) and intact cell-cell junctions 1–3. 
Because they are highly bioactive and can be easily handled and manipulated, cell sheets can be used to build 3D 
soft tissues or organs and avoid the defects such as significant cell loss due to trypsinization and difficulty con-
trolling the location of the transplanted cells caused by direct cell injection. The time and thickness of cell sheet 
formation are closely related to the capability of cell proliferation and cell type.
Adipose-derived stem cells (ADSCs) are one of the most common stem cell types to be applied in autoplastic 
transplantation. Compared with other mesenchymal stem cell types isolated from cartilage and bone marrow, 
ADSCs possess the highest proliferation potential and exhibit high tolerance to serum deprivation-induced cell 
apoptosis4. Adipose tissue contains a high content of ADSCs and quantities of 0.7 × 106 ADSCs can be obtained 
per gram of adipose tissue5. Furthermore, adipose tissue is abundant in body and there is no effect on the body 
function after removing a small amount of fatty tissue. Recently, ADSCs sheet transplantation has shown the 
potential to be used for repair and reconstruction of damaged tissues and organs, including myocardial infarc-
tion6,7, diabetic ulcers8 and full-thickness defect wound healing9. However, an effective means to assess the fate 
and distribution of transplanted cell sheets in a serial and noninvasive manner is still lacking.
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To track cell sheet survival and migration in vivo, it is important to be able to provide serial images from weeks 
to months after transplantation. Magnetic Resonance Imaging (MRI) offers an established and high-resolution 
approach to dynamically and persistently detect a small fraction of labeled cells in vitro and vivo. Thus it can 
be used as an ideal tracer method. At present, there are two main groups of paramagnetic contrast agents used 
for MRI, gadolinium (Gd) based chelates and iron oxide (Fe) based particles. Gadolinium rhodamine dex-
tran (GRID) is the most commonly used MR contrast agents in clinical practice. However, GRID significantly 
increases the level of reactive oxygen species (ROS) and affects cell proliferation10. Iron is a basic element in 
cellular metabolism, and involved in a series of crucial physiological events, such as oxygen transport, mitochon-
drial respiration, and DNA synthesis11. Many studies have shown labeling with optimized superparamagnetic 
iron oxide nanoparticles (SPIO) does not trigger cell apoptosis, and does not impair cell survival or prolifera-
tion capacity12–15. SPIOs are divided into three main categories according to different hydrodynamic diameters, 
including oral SPIO, standard SPIO, and ultrasmall SPIO (USPIO). For USPIO, the hydrodynamic diameter size 
of nanoparticle is less than 50 nm16. MR signal enhancement is closely associated with particle size, and the 
smaller iron oxide provided greater signal enhancement and prolonged signal enhancement17. From early reports, 
USPIO has been evaluated as an MR contrast agent for imaging cells and scaffolds in vitro and in vivo12,18–20. 
Nevertheless, there has been no report on USPIO-labeled cell sheets and their use to further obtain non-invasive 
imaging information on transplanted USPIO-labeled cell sheet in vivo. In this study, we chose ADSCs as seed cells 
and describe a simple protocol to label ADSCs sheets using USPIO at optimized concentration and demonstrate 
the feasibility of noninvasive imaging of labeled ADSCs sheet after transplantation in vivo.
Experimental Procedures
Materials. Ferric citrate, ferrous (II) sulfate heptahydrate (FeSO4.7H2O, 99%) and NaOH were purchased 
from by Sinopharm Chemical Reagent Co., Ltd. (Shanghai, China). Ascorbic acid (AA) was obtained from 
Aladdin Chemical Reagent Co., Ltd. (Shanghai, China). The Cell Counting Kit-8 assay (CCK-8) was purchased 
from Dojindo Laboratories (Japan). Cell culture products and reagents were purchased from Thermo Scientific 
(Rockford, IL, USA). Beagle dogs, at the start of the study 10 months of age, and nude mice of 4 weeks of age were 
provided by the Shanghai sixth people’s hospital Animal Laboratory. The experimental protocol was reviewed 
and approved by the Ethics Committee and is in compliance with the guidelines for the ethical treatment of 
animals made by the International Council for Laboratory Animal Science. The water used in all experiments 
was ultrapure water, which was purified by a Milli-Q Water System (18.2 MΩ cm, Millipore Co., USA). The life 
sciences committees of Shanghai Jiao Tong University approved the experiments, and all experimental procedures 
were in agreement with institutional use and care regulations.
Synthesis and characterization of USPIO. Continuing from our previous studies21,22, herein we devel-
oped a hydrothermal method for controllable synthesis of USPIO nanoparticles. The USPIO nanoparticles were 
prepared by a hydrothermal method using FeSO4·7H2O, ferric citrate and ascorbic acid as raw materials. In brief, 
10 mL FeSO4·7H2O solution was added to a 30 mL ferric citrate solution in a molar ratio of 2:1 under strong stir-
ring at room temperature. 0.6 mmol ascorbic acid as antioxidant was dissolved in the mixture, and then the pH of 
the solution was brought to 10 using a 1.5 M NaOH solution. Subsequently, the obtained precursors were poured 
into a 50 mL Teflon-lined autoclave, which was kept at 200 °C for 10 h and then returned to ambient temperature. 
The resulting solution was dialyzed by MWCO 14 kDa of dialysis bag for 24 h. To remove bacteria, the above 
Fe3O4 nanoparticle solution was then filtered through a 0.22 μ m nylon filter. The crystallinity of the synthesized 
USPIO was determined with an X-ray powder diffractometer (XRD, Rigaku, Japan) using Cu Kα radiation at 
1.5418 Å at a scanning rate of 5° min−1. Zeta potential measrements were carried out using a NICOMP 380 ZLS ζ 
potential/particle sizer (PSS Nicomp, USA). Transmission electron microscopy (FEI Tecnai G2 Spirit Twin, Czech 
Republic) was used to observe the crystal structure and sizes.
Cell cultures. As a common large experimental animal, canines were used in our study for abundant subcu-
taneous fat, their similarity to human physiology and strong disease resistance. The primary culture of Canine 
ADSCs were prepared as reported previously23. Briefly, ADSCs were isolated by an enzymatic digestion method. 
After general anesthesia, primary ADSCs were obtained from fat tissue in the groin of beagle dogs, then digested 
with 0.1% collagenase I for 1 h at 37 °C. The digested cells were collected after filtration through a cell strainer. The 
primary ADSCs were maintained in low glucose Dulbecco modified Eagles (DMEM, Gibco, NY, USA) supple-
mented with 10% fetal bovine serum (FBS, Gibco, NY, USA), 100 U/mL penicillin (Gibco, NY, USA), 100 mg/mL 
streptomycin sulfate (Gibco, NY, USA). The culture medium was replaced every 2–3 days.
Cell sheets preparation and labeling. Canine ADSCs at passages 2 were grown in 12-well plate until cell 
growth reached 80–90% confluence. The polyamine poly-L-lysine (PLL) hydrobromide (Sigma, St Louis, Mo, 
175,000 MW) was used as the transfection agent. Canine ADSCs were incubated with USPIO and 0.75 μ g/ml PLL. 
These culture media containing the USPIO-PLL complex were added to the ADSCs such that the final concentra-
tion of Fe in USPIO was 5 μ g/mL, 10 μ g/mL, 25 μ g/mL, 50 μ g/mL, 100 μ g/mL, respectively. Meanwhile, unlabeled 
ADSCs were used as control. The cell cultures were incubated for 12 h at 37 °C in 5% CO2 atmosphere. After 
incubation for 12 h, cells were washed three times with phosphate-buffered saline (PBS) and further cultured in 
low glucose DMEM supplemented with 10% FBS. For cell sheet labeling, ADSCs at 5 × 104 per cm2 were seeded 
in a 60 mm Temperature-Responsive Cell Culture Surface (Thermo Fisher Scientific, San Jose, CA, USA) until the 
cell growth reached 90%-100% confluence (2–3 days). Then, the optimum concentration of USPIO was used to 
label the ADSCs. Vitamin C catalyzes the hydroxylation of prolyl and lysyl residues in the collagen polypeptide 
chains, allowing interaction of the collagen subunits, adding structural stability to the collagen fibers, thus it plays 
a vital role in the production of collagen24. In this study, the secretion of extracellular matrix were stimulated with 
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100 μ g/mL vitamin C (Sigma, St.Louis, USA) for 3 days, and then 50 μ g/mL vitamin C (Sigma, St Louis, USA) for 
18 days to form the cell sheet. The culture medium was replaced every 2 days.
Prussian blue staining and Iron Quantificationh. After 12 h incubation with varying concentrations 
of USPIO, cells were washed three times with PBS and intracellular iron oxide distribution was detected by Perl’s 
Prussian blue staining kit (Solarbio science & Technology, Beijing, China). Cells were fixed for 15 minutes in 4% 
paraformaldehyde, and then incubated for 25–30 minutes with 10% potassium ferrocyanide, rewashed twice with 
PBS, and counterstained with nuclear fast red for 10 minutes. Cells containing intracytoplasmic blue granules 
were defined to be Prussian blue staining positive (PB-positive). Cells labeled with varying concentrations of 
USPIO were trypsinized and washed 5 times with PBS, then detached, counted and resuspended in a 37% HCl 
solution. The iron content per cell was obtained by inductively coupled plasma mass spectroscopy (ICP-MS, 
MICI, Suisse). Three replicates at each concentration were measured for statistical analysis.
Cellular cytotoxicity assessment. CCK-8 is a sensitive non-radioactive colorimetric assay for detect-
ing the number of viable cells in cytotoxicity and cell proliferation assays25. The sensitivity of cell proliferation 
assays using CCK-8 is higher than other tetrazolium salts, such as XTT, MTT, WST-1 or MTS25. According to the 
manufacturer’s instructions, cellular cytotoxicity of different concentrations of USPIO-labeled ADSCs was deter-
mined with a cell counting Kit-8 (Dojindo, Tokyo, Japan). 100 μ L ADSCs suspensions (2 × 103/well) were added 
to 96-well plates. The cells were cultured to 80–90% confluence, different concentrations of USPIO and 0.75 μ g/ml 
PLL was added to each well for 12 hours incubation. After washing three times with PBS, ADSCs were contin-
uously cultured in 100 μ L low glucose DMEM supplemented with 10% FBS. 10 μ L of CCK-8 was added in 96 
wells every 24 hours. After 2 h incubation, optical density (OD) values at 450 nm were measured with a standard 
microplate reader (TECAN, Männedorf, Switzerland). This experiment was continued for 7 days, then growth 
curves were created to compare varying concentrations of USPIO-labeled and unlabeled cells.
Cellular apoptosis. Varying concentrations of USPIO and 0.75 μ g/ml PLL were added to the cultures for 
12 hours. According to the manufacturer’s instructions, apoptotic cells rate were assessed by an Annexin V-FITC/
PI detection kit (BD Biosciences; San Diego, CA, USA). Briefly, the cells were collected by centrifugation at 
500× g for 3 min and washed three times with cold PBS. Approximately 1 × 106 cells were resuspended in 250 μ L 
of manufacturer-supplied 1 × binding buffer, and USPIO-labeled and unlabeled ADSCs were incubated with 2 μ L 
of annexin V-FITC and 10 μ L of propidium iodide (PI). After 30 minutes incubation in the dark at 25 °C, the cells 
were then washed twice with annexin medium and analyzed with flow cytometer (Beckman Coulter, Miami, FL, 
USA).
Transmission electron microscope. Transmission electron microscopy (FEI Tecnai G2 Spirit Twin, Czech 
Republic, operating at 80 kV) was used to analyse the intracellular distribution of USPIO in USPIO-labeled cells. 
First, the optimal concentration of USPIO that give the high transfection efficiency without any effects on cell 
growth was screened via the above steps. Then, the optimal concentration of USPIO-labeled and unlabeled 
ADSCs was fixed in 2.5% glutaraldehyde for 4 h, post-fixed in 1% osmium tetroxide in the same buffering solu-
tion for 2–3 h, contrasted in block with 0.5% uranyl acetate for 2 h, dehydrated using graded ethanol/acetone and 
included in Araldite® resin. The ultra-thin cuts (50–60 nm) were contrasted in alcoholic solution saturated with 
uranyl acetate and lead citrate for 20 minutes, then observed and analyzed in FEI Tecnai G2 Spirit Twin.
Multipotent differentiation of USPIO-labeled ADSCs. To observe the differentiation potential of 
USPIO-labeled ADSCs, osteoblast, myoblast and adipocyte differentiation assays were performed in vitro. The 
unlabeled ADSCs were used as a control group. Osteogenic differentiation of ADSCs was cultured under the 
osteogenic induction medium for 3 weeks, containing 90% low glucose DMEM supplemented with 10% FBS, 
dexamethasone, 50 μ g/ml ascorbic acid and b-glycerol phosphate. For adipogenic differentiation, ADSCs were 
incubated in adipogenic medium for 3 weeks, which consists of 90% DMEM supplemented with 10% FBS, insu-
lin, indomethacin, 1-methyl-3-isobutylxanthine, and dexamethasone. Osteogenic and adipogenic differentiation 
were detected by alizarin red staining and oil red staining in accordance with manufacturer’s instructions, respec-
tively. In a previous study, our group isolated ADSCs and induced them into myoblast with 5-Azacytidine in vitro, 
and successfully treated stress urinary incontinence of rat26. Similarly, we also induced the myogenic differenti-
ation of USPIO-labeled and unlabeled ADSCs by 5-Azacytidine for 3 weeks. The muscle protein expression of 
Desmin (1:300 antibody dilution, SantaCruz Inc, Santa Cruz, CA) was detected by indirect immunofluorescence 
staining and observed under the fluorescence microscope.
Transplantation of USPIO-labeled ADSC sheet. For easy operation and elimination of immune rejec-
tion, immune-deficient nude mice were used as experimental animal for in vivo transplantation further assessed 
the fate of the USPIO-labeled cells in the transplanted areas by MRI. After 12 h incubation at the optimal concen-
tration of USPIO-containing medium, ADSCs were washed three times with PBS, and then continuously cultured 
for 21 days and formed cell sheets with the stimulation of vitamin C. The culture medium was replaced every 2 
days. As a flexible and thin sheet tissue composed of cells and ECM, the cell sheet is hard to transplant smoothly 
under the skin. After cell sheet formation, USPIO-labeled and unlabeled ADSC sheets were folded and stacked 
to cell sheet “pellets” with cell scraper, which made it easier to transport the sheets and fix them in vivo. Before 
transplantation of the cell sheet “pellets”, nude mice (4 weeks) were anesthetized with pentobarbital-sodium (25–
30 mg/kg ip). A 1.5 cm incision was made in the dorsal skin, and underlying space between skin and muscle was 
exposed. Then, three cell sheet “pellets” from each group were transplanted onto the under skin space and the 
incision was closed with 5–0 nylon sutures.
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Magnetic resonance imaging in vitro. Varying concentrations of USPIO (5 μ g Fe/mL, 10 μ g Fe/mL, 25 μ 
g Fe/mL, 50 μ g Fe/mL, 100 μ g Fe/mL) labeled and unlabeled cells were washed twice with PBS, trypsinized, fixed 
through incubation with 4% paraformaldehyde for 15 minutes and cells collected at 500× g centrifugation for 
3 min. Then, 2 × 105 cells were resuspended with 1 mL PBS in 1.5 mL tubes. MR imaging (3.0 T; PharmaScan, 
Bruker, Germany) was used to determine the sensitivity of MRI for the detection of varying concentrations of 
USPIO-labeled cells using multi-slice T2- weighted spin echo sequences. Imaging parameters for T2-weighted 
turbo spin-echo (SET2WI) were as follows: repetition time (TR) = 470.1 ms, echo time (TE) = 7.5 ms, field of 
view (FOV) = 2.5 × 2.5 cm2, matrix = 384 × 384, slice thickness = 0.2 mm, spacing layer = 0.45 mm, and flip 
angle = 15°. An equal amount of PBS in 1.5 mL tubes was used as control.
Magnetic resonance imaging in vivo. To further observe the magnetic resonance images of transplanted 
USPIO-labeled ADSCs sheet, 50 μ g Fe/mL USPIO-labeled and unlabeled ADSCs sheet “pellets” were examined 
by MRI 1 week, 4 weeks and 12 weeks after transplanting the cell sheets. To perform the MRI, animals were anes-
thetized with pentobarbital-sodium (25–30 mg/kg ip). After a gradient-echo localizer in three spatial directions, 
the T2-weighted MR images were acquired using Rapid Acquisition with Relaxation Enhancement sequence, 
specific parameter as follows: TE = 71 ms, TR = 3500 ms, RARE factor = 8, number of averages = 8, slice thick-
ness = 1 mm, FoV = 70 × 100 mm, matrix = 384 × 384.
Histopathology. In week 1, 4, 12 after labeling and embedding into nude mice, nude mice were sacrificed 
and transplanted USPIO-labeled and unlabeled ADSC sheet “pellets” were removed and further fixed by 4% 
paraformaldehyde for 24 h, followed by paraffin embedding and sectioning (5 μ m in thickness). The sections were 
HE-stained for microscopic examination. Meanwhile, the presence of iron oxide in the transplanted area was 
detected by Prussian blue staining. The specific procedures of Prussian blue staining are described in the Prussian 
blue staining and Iron Quantification section. Finally, the differentiation of ADSC sheets in vivo was investi-
gated 12 weeks after transplantation. Alizarin red staining (paraffin section), oil red staining (frozen section) 
and immunohistochemical staining (Desmin, 1:300 antibody dilution, paraffin section) were used to analyze the 
osteogenic, adipogenic and myogenic differentiation, respectively.
Statistical analysis. All data are expressed as means ± SD. To identify significant differences in the labeling 
efficiency, cellular apoptosis rate and grey value of MR imaging, one-way analysis of variance and unpaired stu-
dent t test was applied. Cellular cytotoxicity of varying concentration of USPIO-labeled and unlabeled groups 
were analyzed with repeated measurement analysis of variance. P values less than 0.05 were identified to be sta-
tistically significant differences.
Results and Discussion
Flow cytometry analysis indicated, the primary cultured ADSCs in our study were negative for hematopoietic 
markers CD34 and CD45, and were strongly positive for MSC-related markers CD44, CD90 and CD105, which 
confirmed the stem cell origin of ADSCs (Supplementary Data 1). Transmission electron microscopy (TEM) 
images were used to observe the crystal structure and sizes. TEM images showed the monodisperse USPIO nan-
oparticles were approximately spherical with an average diameter of 10 ± 2 nm (Fig. 1A). High-resolution trans-
mission electron microscopy (HRTEM) of a representative USPIO was observed in Fig. 1B. The lattice distance 
was measured to be 0.486 nm, consistent with the standard cubic Fe3O4 structure27. The USPIO were further 
characterized by the X-ray diffraction (XRD) (Fig. 1C). The XRD diffraction peaks of the as-synthesized USPIO 
were also shown to be due to the cubic Fe3O4 structure (JCPDS no.19–0629). The excellent saturation moment 
of the USPIO nanoparticles was ~71 emu g−1, indicating that the synthesized USPIO are superparamagnetic, 
which facilitate the magnetic resonance imaging of medical diagnosis. The hydrodynamic size of nanoparticles in 
water was approximately 10.5 ± 5.169 nm (PDI = 0.122), which was slightly bigger than the size in TEM. It may 
be attributed to the hydration of the ligand on the surface of USPIO in ultrapure water, in accordance with the 
published literature28.
USPIO nanoparticles have attracted considerable interest due to their biocompatibility, biodegradability and 
excellent magnetic properties29. An ideal tracer agent requires high detection sensitivity while not having an 
influence on the activity of cells. There is considerable differences in the doses of USPIO reported in literature. 
Chen et al.14 showed labeling endothelial are progenitor cells with USPIO at a concentration of 28 μ g Fe/mL for 
24 h was nearly 100% efficient and did not affect cell viability. Paik et al.30 showed that iron nanoparticles used at a 
concentration of 1% were non-toxic to the bone marrow cells and both the secretion of cytokines and expression 
of cell surface markers will not be affected. Oude-Engberink et al.18 confirmed that incubating human monocytes 
with USPIOs (1000 μ g Fe/mL) results in efficient labeling detectable on MR images and does not affect cellular 
activity and activation markers such as cytokine production and cell migration. Furthermore, it has been proven 
that iron nanoparticles induce a significant increase in the production of ROS and subsequent microtubule 
remodeling31. Overproduction of ROS have been shown to be associated with various pathologic changes, such as 
cell structural damage, carcinogenesis, inflammation, radiation and reperfusion injury32. The uptake of iron oxide 
particles by cells is highly dependent on the cell types, cell size, surface charge, and coating of the particles. There 
is no single standard dosage that is appropriate for all cell types, thus we firstly explore the optimum concentra-
tion of USPIO for canine ADSCs labeling. As a cationic polymer, PLL can effectively boost the intracellular uptake 
of the nanoparticles through electrostatic interactions15. Compared with iron oxide alone, the iron nanoparticles 
and PLL mixture is more effective in achieving desired relaxation time12. Various concentrations of PLL have been 
used in the literature reports, from 0.375 μ g/mL to 1.5 μ g/mL12,33,34. Excessive PLL can form toxic aggregates and 
inhibit the nano-sized iron oxide incorporation in the cells, thus we chose a moderate concentration of PLL of 
0.75 μ g/mL. In this study, the zeta potential of 0.75 μ g/mL PLL was detected as 5.33 mV, and it gradually dropped 
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from 4.81 mV to 2.79 mV with mixing the increasing concentrations of USPIO from 5 μ g Fe/mL to 100 μ g Fe/
mL. The positive lysine charges of the PLL/USPIO complexes balance the negative phosphate charges on the cell 
membrane, and further enhance the cell endocytosis35, which could contribute to the iron nanoparticles uptake 
and obviously reduce the dosage of USPIO.
The iron content per cell increased with increasing incubation time, and reached saturation at 12 h of incu-
bation (Supplemental Data 2). After incubation for 12 h with varying concentrations of USPIO nanoparticles, 
the labeling efficiency was detected by Prussian blue staining, as shown in Fig. 2A. The USPIO-labeled ADSCs 
exhibited an increasingly strong blue staining with the increasing concentrations of USPIO from 5–100 μ g Fe/mL. 
Intracellular blue spots represent spread USPIO nanoparticles and mostly concentrated in the perinuclear region 
of the cytoplasm. ICP-MS in Fig. 2B showed the average iron content was 0.17 ± 0.036 pg/cell for 0 μ g Fe/mL, 
5.29 ± 1.225 pg/cell for 5 μ g Fe/mL, 6.63 ± 1.117 pg/cell for 10 μ g Fe/mL, 17.07 ± 2.325 pg/cell for 25 μ g Fe/mL, 
28.48 ± 3.806 pg/cell for 50 μ g Fe/mL,42.42 ± 6.843 pg/cell for 100 μ g Fe/mL. This indicated the iron content per 
cell is proportional to the iron concentrations in a range of 5–100 μ g/mL (P < 0.05).
CCK-8 assay was used to detect the proliferation of USPIO-labeled cells and assess the cellular cytotoxicity of 
USPIO. The growth curves labeled cells with varying concentration of USPIO and unlabeled cells ware shown in 
Fig. 3. The data indicate, compared with unlabeled cells, no cellular cytotoxicity due to USPIO was found in the iron 
concentration range of 5–50 μ g/ml and cells incubated with PLL alone, p > 0.05. The OD value of 100 μ g Fe/mL 
labeled cells was significantly lower than unlabeled cells (p < 0.05). These results suggested that USPIO was not 
cytotoxic with good biocompatibility to ADSCs with a final iron concentration of less than 50 μ g/ml.
Furthermore, annexin V-FITC/PI double staining was performed to analyze the proportion of apoptotic cells 
in the varying concentration of USPIO-labeled and unlabeled cells. The results are shown in Fig. 4. The propor-
tion of apoptotic cells in the USPIO-labeled cell samples was (2.9 ± 0.50)% for 5 μ g/ml, (2.9 ± 0.32)% for 10 μ g/ml, 
(3.1 ± 0.36)% for 25 μ g/ml, (3.4 ± 0.25)% for 50 μ g/ml, (8.8 ± 1.75)% for 100 μ g/ml, whereas the proportion of 
apoptotic cells in the unlabeled cell (0 μ g/ml) samples was (2.7 ± 0.42)% and cells incubated with PLL alone was 
(2.7 ± 0.46)%. Although the populations of apoptotic cells increased with concentration of USPIO, no significant 
difference was observed between the unlabeled and labeled cells at an iron concentration of 5–50 μ g/ml, p > 0.05. 
Furthermore, the difference between unlabeled cells and cells incubated with PLL alone was not found to be 
statistically significant, p = 0.892. Compared with unlabeled cells, a statistically significant increase of apoptosis 
rate was apparent at 100 μ g Fe/ml concentrations, p < 0.01. Thus, according to the labeling efficiency, cellular 
cytotoxicity and cellular apoptosis rate assessment, we chose to use USPIO at a Fe concentration of 50 μ g/ml for 
a 12 h incubation, which can most efficiently mark cells and did not impair the cell survival, self-renewal, and 
proliferation capacity, and this concentration was screened to use for further experiments.
Figure 1. Characterization of the as-prepared USPIO. (A) TEM image, scale bar: 100 nm. (B) HRTEM image 
of USPIO, scale bar: 10 nm. (C) XRD patterns of the as-prepared USPIO, (D) magnetization curves measured at 
300 K (D).
www.nature.com/scientificreports/
6Scientific RepoRts | 7:42793 | DOI: 10.1038/srep42793
After 12 h incubation with an iron concentration of 50 μ g Fe/ml, the uptake of USPIO particles into the 
cells was investigated using transmission electron microscopy. In Fig. 5A–D, similar to unlabeled ADSCs, 
the cellular structure and morphology of USPIO-labeled ADSCs were integral and clear, and the cell mem-
brane did not appear to be damaged. USPIO was taken into cell through a membrane adsorption process 
and subsequent intracellular (non-nuclear) localization is found in endosomes20. Dark black spots indicate 
USPIO particles. A fraction of USPIO particles were found to be adhered to the cell plasma membrane and 
with no distribution in the nucleus, while most of them were incorporated into intracellular and aggregated 
in large lysosomes.
Several studies have suggested labeling stem cells with iron oxide in an appropriate concentration does 
not adversely affect the cell differentiation ability, including chondrogenic differentiation36, myogenic dif-
ferentiation37, adipogenic differentiation38 and neural differentiation39. However, the biological effects of iron 
nanoparticles on osteogenic differentiation of stem cells remain controversial. Xiao et al.40 demonstrated that 
superparamagnetic iron oxide could promote osteogenic differentiation of rat ADSCs, while Fan et al.41 showed 
the osteogenic and adipogenic potential of ADSCs were inhibited after SPIO labeling. One possible reason is 
that SPIOs can influence cell mobilization, involve the activation of relevant signaling pathway and further affect 
osteogenic differentiation ability42. High iron nanoparticle loads could have negative effects on cell viability and 
differentiation, thus it is important to choose the appropriate concentration. In our study, the USPIO-labeled 
ADSCs maintained a good differentiation potential and no significant difference was observed in the myogenic 
(Fig. 6A vs Fig. 6D), osteogenic (Fig. 6B vs Fig. 6E) and adipogenic (Fig. 6C vs Fig. 6F) differentiation ability in 
vitro between the USPIO-labeled and unlabeled groups (Fig. 6).
To test the detectability in MRI, 2 × 105 varying concentrations of USPIO-labeled and unlabeled ADSCs were 
placed in 1.5 mL tube (Fig. 7A) and were detected as strongly hypointense areas on T2-weighted images (Fig. 7B). 
A good correlation between the image grey-scale value and the concentrations of USPIO in the MR images was 
observed. Lighter gray represents lower iron concentrations and darker gray represents higher iron concentra-
tions. There are significant differences in the gray value among varying concentrations of USPIO. Moreover, the 
Figure 2. Prussian blue staining and iron quantification. (A): ADSCs were incubated for 12 h with varying 
iron concentrations of USPIO nanoparticles. Iron particles are stained blue (× 200), scale bars: 100 μ m. (B): 
quantitative analysis of iron oxides, the iron content per cell was detected by ICP-MS, the iron uptake increased 
with iron concentrations at a range of 5–100 μ g/mL, *p < 0.05.
Figure 3. Cellular cytotoxicity assessment. ADSCs were co-cultured with USPIO nanoparticles at iron 
concentrations of 0–100 μ g/ml, growth curves of USPIO-labeled ADSCs were obtained by CCK-8 assay. 
Compared with unlabeled cells, there was no cellular cytotoxicity of USPIO in the iron concentration range 
of 5–50 μ g/ml and cells incubated with PLL alone, p > 0.05, while cell proliferation was inhibited at the iron 
concentration of 100 μ g/ml, p < 0.05.
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gray difference can be easily identified by the naked eye at concentrations greater than or equal to 25 μ g Fe/ml. 
These results indicated that MRI can efficiently detect USPIO-labeled ADSCs and that the intensity of the signal 
is proportional to the concentrations of USPIO.
Vitamin C was added to culture medium to accelerate native ECM secretion and generate a three dimen-
sional tissue-like and contiguous cell sheets43. Various types of ECM and membrane proteins penetrate into 
the cell sheets and play a role as adhesive agents to limit cell distribution and migration. Thus cell sheets 
are intact whole before and after transplantation. Furthermore, MR imaging is applicable to continuously 
track the migration and location of transplanted cells, even for a small number of labeled cells (5 × 103 to 
1 × 104)44 or single cell images45. For cell sheets, the cell number is very large. The number of initial seed-
ing cells is 1.05 × 106 cells per sheet in our experiments. The characteristics of large quantities of cells are 
favorable for detection of USPIO-labeled cell sheet by MRI imaging. For USPIO, the effect of MR contrast 
agents is not observed directly on the image, but the change of the relaxation rate of water protons is detect-
able by MRI46. Thus, iron oxide nanoparticles are seen as hypointensity or negative contrast on T2-weighted 
and T2*-weighted images and often referred to as “negative” contrast agents. In vitro MR imaging showed, 
compared with unlabeled cells or PBS, a visible hypointense signal can be provided at the concentrations of 
25 μ g Fe/mL.
For in vivo MR imaging, the USPIO-labeled cell sheet “pellets” implants were visible as a hypointense area at 
the transplantation site and three-dimensional images could be further provided. Several studies have suggested 
the use of iron oxide nanoparticles via cell labeling as an effective MR contrast for detecting grafted cells and 
tissue over long times in animal experiments. Bulte et al.20 showed SPIO-labeled oligodendroglial progenitors 
can be readily detected in vivo for 6 weeks after transplantation. Neri et al.44 proved that low numbers of viable 
SPIO-labeled human neural precursor cells (5 × 103 to 1 × 104) could be efficiently detected in the adult murine 
brain after transplantation, and it could be tracked for at least 1 month in vivo. Furthermore, Guzman et al.47 
detected the targeted migration and distribution of SPIO-labeled clusters of cells up to 18 weeks. For monitoring 
of cell sheet transplantation, we further localize USPIO-labeled cell sheet by MRI after transplantation in the sub-
cutaneous area of nude mice for at least 12 weeks. At 1 week, 4 weeks and 12 weeks after transplantation into the 
subcutaneous area of nude mice, we explored whether USPIO-labeled ADSCs sheet “pellets” could be localized by 
MRI, as shown in Fig. 7C. One week after implantation, regions of hypointense signal in T2 images were found in 
the transplantation sites of 50 μ g Fe/ml USPIO-labeled ADSCs sheet “pellets” and no MRI signals were detected 
when similar volume unlabeled ADSCs sheet “pellets” were transplanted. The signal was visualized up to 4 weeks 
and even 12 weeks after transplantation. Thus, our result showed USPIO-labeled ADSCs sheets can be easily and 
clearly detected in vivo and has persisted for at least 12 weeks. However, compared with 1 week after implantation, 
grey-scale value and area of hypointense signal nearly remain the same at 4 weeks after implantation and deceased 
at 12 weeks.
Histological analysis in Fig. 8A revealed that USPIO particles were a granular brown substance which was 
located mainly in the cytoplasm and there was no difference in cell morphology between labeled and unlabeled 
cells in the HE stained section. Prussian Blue staining revealed positive stained granules exclusively in the trans-
plants of USPIO-labeled cells and presented an even distribution within the cell sheet. However, the blue-stained 
iron particles in the cytoplasm decrease gradually from week 1 to week 12 when these were transplanted into 
subcutaneous area (Fig. 8B). Signal intensity was well correlated with iron accumulation. In our study, over 12 
weeks the signal intensity of USPIO-labeled cell sheet reduced gradually with time, which was also proven by 
Prussian Blue staining. We analyzed the possible cause of the changes of signal intensity, including: 1) A fraction 
Figure 4. Cellular Apoptosis rate for varying iron concentration labeling. ADSCs were treated with USPIO 
nanoparticles at iron concentrations of 0–100 μ g/ml and PLL alone. The cell apoptosis was demonstrated 
with flow cytometry. Compared with unlabeled cells (0 μ g/ml), incubation of ADSCs with PLL alone did not 
affect the rate of apoptotic cells, *p = 0.892, and no significant difference was observed at an iron concentration 
of 5–50 μ g/ml, **p > 0.05. However, USPIO could induce increased apoptosis of ADSCs at 100 μ g Fe/ml 
concentrations, ***p < 0.01.
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of the USPIO-labeled cells gradually migrating out of the cell sheet. 2) The iron particles in the magnetic labeled 
cells can be passed to offspring cells, and the concentration of iron particles can be diluted and decrease during 
cell division. 3) Iron oxide loading has been shown proved to increase activity of lysosomal cathepsin D, and the 
latter induces the cellular iron to gradually degrade in lysosomes48. Although most of the iron particles remains 
intact in the endosome49, some amount of the nano-sized iron oxide can be released from the labeled cell by 
exocytosis with time.
In addition, the osteogenic, adipogenic and myogenic differentiation were measured to evaluate the cell dif-
ferentiation in vivo (Fig. 8C). The result showed, apart from brown iron particle deposited within USPIO-labeled 
cell sheets, no spontaneous cell differentiation towards bone, fat and muscle was observed in both USPIO-labeled 
and unlabeled ADSCs sheets. Our study certified the feasibility of tracking ADSCs sheet with USPIO in vivo for a 
long time (12 weeks), however, due to the xenoplastic transplantation of ADSCs sheet, it is hard to detect the cell 
migration in this study, and further studies may focus on the cell sheet migration towards deep anatomical sites 
in homoplastic transplantation.
Conclusion
In summary, the ADSCs sheet can be effectively labeled with 50 μ g Fe/ml USPIO and 0.75 μ g/mL PLL. The par-
ticles did not impair cell survival, self-renewal, and proliferation capacity. USPIO might be feasible for in vivo 
labeling of the ADSCs sheets using the optimal concentration of 50 μ g Fe/ml. This level of concentration did not 
influence the cells’ activity nor the cell apoptosis rate. MRI scanning on T2WI sequences can effectively track 
Figure 5. Transmission electron microscope for USPIO-labeled cells. Canine ADSCs were treated with USPIO 
nanoparticles at iron concentrations of 50 μ g/ml, Transmission electron microscopy indicated, compared with 
unlabeled cells, the USPIO labeled cells can also keep its inherent structure and morphology, and labeled ADSCs 
had iron nano-particles (black granular material) in the cytoplasm, as indicated by arrowheads. (A): USPIO 
labeled ADSCs, × 1650, scale bar: 5 μ m; (B): USPIO labeled ADSCs, × 11000, scale bar: 0.5 μ m; (C): unlabeled 
ADSCs, × 1650, scale bar: 5 μ m; (D): labeled ADSCs, × 11000, scale bar: 0.5 μ m.
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Figure 6. Myogenic, adipogenic and osteogenic differentiation of USPIO-labeled ADSCs after 3 weeks 
induction. Red-colored lipid vacuoles were detected by Oil Red staining. Calcium deposits were found in 
osteogenically differentiated ADSCs. Myoblast differentiation exhibited a significant upregulation of α -SMA 
expression. (A) α -SMA expression in USPIO-labeled ADSCs. (B) Oil red staining of USPIO-labeled ADSCs. 
(C) Alizarin red staining of USPIO-labeled ADSCs. (D) α -SMA expression in unlabeled ADSCs. (E) Oil red 
staining of unlabeled ADSCs. (F) Alizarin red staining of unlabeled ADSCs. Scale bars: 100 μ m.
Figure 7. Tracking of USPIO-labeled ADSCs sheet by MRI. (A): Unlabeled (control) and 50 μ g Fe/mL labeled 
ADSCs sheets were gathered to cell sheet “pellets” with cell scraper, about diameter 1 cm and length 1 cm, and 
then subcutaneously transplanted in the back of nude mice. (B): T2-weighted MR images of USPIO-labeled 
ADSCs in vitro. 2 × 105 ADSCs were treated with USPIO at the iron concentrations of 0–100 μ g/ml and PBS 
was taken as control, the signal intensity is proportional to the concentrations of USPIO, the gray difference can 
be easily identified by naked eye at the iron concentration of greater than or equal to 25 μ g/ml. (C): MRIs were 
examined at 1 week, 4 weeks, and 12 weeks after USPIO-labeled ADSCs sheet transplantation, white arrows 
represent the area of the USPIO-labeled and unlabeled ADSCs sheet, scale bar: 1 cm.
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the USPIO nanoparticles labeled ADSCs in vivo for at least 12 weeks. MRI can be used to continuously track the 
ADSCs sheet labeled with USPIO transplanted into nude mice and provide a non-invasive method to understand 
the fate of the labeled cells in the transplanted areas.
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